ADAR1 Capital Management »

Black Hawk Acquisition Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Black Hawk Acquisition Corp (BKHAU) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Black Hawk Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Black Hawk Acquisition Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Hawk Acquisition Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $152k 15k 10.15

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Black Hawk Acquisition Corp

Clear Street
Polar Securities
HGC Investment Management
Westchester Capital Management
Verition Fund Management
Gabelli Securities
Gabelli Funds
David W. Seeley
Tower Research Capital

View all funds holding Black Hawk Acquisition Corp